论文部分内容阅读
问题:在伴有3种以上心血管危险因素的高血压患者(40～79岁)中,氨氯地平联用培哚普利还是阿替洛尔联用苄氟噻嗪更能减少心血管终点事件？
Question: Amlodipine or atenolol in combination with bendroflumethin in patients with hypertension (40-79 years of age) with more than three cardiovascular risk factors is more likely to reduce cardiovascular endpoints event?